We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Mouse Model Mimics Human Prostate Cancer

By Biotechdaily staff writers
Posted on 22 Sep 2004
Cancer researchers have found that lack of one or both alleles for the Rb tumor suppressor gene in cells of the prostate glands of a genetically engineered line of mice was sufficient to trigger the development of a precancerous condition similar to the earliest stages of human prostate cancer.

Investigators at the Fred Hutchinson Cancer Research Center (Seattle, WA, USA; www.fhcrc.org) worked with a line of mice that had been genetically engineered to lack one or more alleles for the Rb gene in cells of the prostate gland while maintaining the normal genetic content in all other cells of the body.

They reported in the September 1, 2004, issue of Cancer Research that mice lacking one or both alleles developed a precancerous condition called focal hyperplasia. More...
While this condition resembles the earliest stages of human prostate cancer, the mice failed to develop malignant cancers during an entire year of observation.

The authors believe that this mouse model will allow them to search for additional genetic factors that lead from focal hyperplasia to full-blown cancer. "We have addressed this by using a mouse system that allows us to selectively eliminate genes in the epithelial cells of the prostate. Our experimental approach allows us to closely mimic what happens in man and gives us a glimpse into the natural history of the disease that we have not had before,” explained senior author Dr. Norman Greenberg, professor of clinical research at the Fred Hutchinson Cancer Research Center.





Related Links:
Fred Hutchinson Cancer Research Center

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Steam Sterilizer
Hi Vac II Line
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.